NCT05771857View on ClinicalTrials.gov

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

CompletedOBSERVATIONAL

Enrollment

415

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

October 1, 2021

Conditions

COVID-19 PandemicObesity

Interventions

DEVICE

Obesity

the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19

Trial Locations (1)

9999

younes Oujidi, Berkane

All Listed Sponsors

lead

Mohammed VI University Hospital

OTHER

NCT05771857 - Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19 | Biotech Hunter | Biotech Hunter